Yumanity Therapeutics has recently licensed a prodrug invented at the University of Arizona (UA), adding it to the company’s expanding platform of potential therapies for neurodegenerative diseases like amyotrophic lateral sclerosis (ALS). Neurodegenerative diseases result from errors made during the building and folding processes of proteins within the cell. In 2009, UA…
Novel Prodrug with Potential for ALS and Like Diseases Acquired by Startup, Yumanity Therapeutics
Astrocyte: the Star of Motor Neuron Disease
In this video by The University of Edinburgh, watch Chen Zhao from the School of Clinical Sciences present her three minute thesis entitled “Astrocyte: the Star of Motor Neuron Disease”. Learn more about ALS here: https://bit.ly/ALSNewsToday…
A Strong Voice for MND
In this MND Australia video, “Kirsten Harley speaks about her experience living with motor neurone disease at Parliament House, Canberra, 24 February 2016.” Learn more about ALS here: https://bit.ly/ALSNewsToday…
Herantis Pharma announced that it has received a positive opinion from the European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) on its application for orphan drug designation for CDNF as a potential treatment for amyotrophic lateral sclerosis (ALS). A positive opinion is the first step toward orphan drug designation which, in…
Stem Cell Research and Motor Neurone Disease
“Professor Siddharthan Chandran is Director of the Euan MacDonald Centre for Motor Neurone Disease Research at the University of Edinburgh.” Learn more about ALS here: https://bit.ly/ALSNewsToday…
ALS Awareness #BeyondTheBucket: Embracing June
In this Embracing Life Through Love Inc. video, get to know more about the #beyondthebucket campaign, which has the “goal to help people learn more about what ALS actually is and the effect it has on the patients and families it effects.” Learn more about ALS here: https://bit.ly/ALSNewsToday…
The California Institute for Regenerative Medicine (CIRM)’s Independent Citizens Oversight Committee has approved a $6.3 million grant to fund a research team’s work into a new human embryonic stem cell-based therapy, involving astrocytes, to rescue and restore neurons damaged as a consequence of amyotrophic lateral sclerosis (ALS). Team members, from the University of…
Les Turner ALS Foundation: Hope Through Caring
In this video, get to know more about the work of the Les Turner ALS Foundation. Learn more about ALS here: https://bit.ly/ALSNewsToday …
7 ALS Headlines You Can’t Miss
1 – 7 Ways to Diagnose ALS Learn more about the different ways to diagnose ALS. Read full article: https://bit.ly/1UWLNAI 2 – ALS Gene Drives Disease Development Through Neuroinflammation, Researchers Find Mutations in the C9orf72 gene are the most common genetic cause leading to amyotrophic…
Aggregates of dipeptide repeat proteins produced by the mutant gene C9orf72 — the most common genetic cause of amyotrophic lateral sclerosis — are toxic to neurons through interactions with a protein intended to clear cells of defective proteins, scientists reported. The findings provide a very specific focus for future drug…
Recent Posts
- After 15 years as an ALS caregiver, I’m still learning from others
- Early PrimeC use slows ALS progression, reduces complication risk
- Learning ALS self-advocacy involves being a little pushy
- Brain implant decodes finger moves so paralyzed patients can type
- Grant funds new ALS treatment approach targeting TDP-43 pathway